Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP501636.RASdQ-LWWoCkPOa2DJbGeyiWPtQFhxBgTVAJcoSTMf_mM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP501636.RASdQ-LWWoCkPOa2DJbGeyiWPtQFhxBgTVAJcoSTMf_mM130_assertion type Assertion NP501636.RASdQ-LWWoCkPOa2DJbGeyiWPtQFhxBgTVAJcoSTMf_mM130_head.
- NP501636.RASdQ-LWWoCkPOa2DJbGeyiWPtQFhxBgTVAJcoSTMf_mM130_assertion description "[Analysis of clinical data in the PKD1 group (N = 146) versus the PKD2 group (N = 20) showed a milder form of the disease in the latter, with a later age at diagnosis (27.4 versus 41.4 yr, P = 0.0002), later age of onset of ESRD (53.4 versus 72.7 yr, P < 0.0001), later age of diagnosis of hypertension (34.8 versus 49.7 yr, P = 0.001) and lower prevalence of hypertension at younger ages.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP501636.RASdQ-LWWoCkPOa2DJbGeyiWPtQFhxBgTVAJcoSTMf_mM130_provenance.
- NP501636.RASdQ-LWWoCkPOa2DJbGeyiWPtQFhxBgTVAJcoSTMf_mM130_assertion evidence source_evidence_literature NP501636.RASdQ-LWWoCkPOa2DJbGeyiWPtQFhxBgTVAJcoSTMf_mM130_provenance.
- NP501636.RASdQ-LWWoCkPOa2DJbGeyiWPtQFhxBgTVAJcoSTMf_mM130_assertion SIO_000772 8915974 NP501636.RASdQ-LWWoCkPOa2DJbGeyiWPtQFhxBgTVAJcoSTMf_mM130_provenance.
- NP501636.RASdQ-LWWoCkPOa2DJbGeyiWPtQFhxBgTVAJcoSTMf_mM130_assertion wasDerivedFrom befree-20140225 NP501636.RASdQ-LWWoCkPOa2DJbGeyiWPtQFhxBgTVAJcoSTMf_mM130_provenance.
- NP501636.RASdQ-LWWoCkPOa2DJbGeyiWPtQFhxBgTVAJcoSTMf_mM130_assertion wasGeneratedBy ECO_0000203 NP501636.RASdQ-LWWoCkPOa2DJbGeyiWPtQFhxBgTVAJcoSTMf_mM130_provenance.